These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17659034)

  • 21. [Simultaneous occurrence of lupus erythematosus and hepatic porphyria--coincidence or chance association?].
    Laux B; Korting GW
    Z Hautkr; 1985 Nov; 60(21):1714-6, 1721-4. PubMed ID: 4072325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lupus Erythematosus Affecting the Genitalia: An Unusual Site.
    Del Alcázar-Viladomiu E; López-Pestaña A; Tuneu-Valls A
    Actas Dermosifiliogr (Engl Ed); 2018; 109(1):78-80. PubMed ID: 28709618
    [No Abstract]   [Full Text] [Related]  

  • 23. Managing cutaneous vasculitis in a patient with lupus erythematosus.
    Pullen RL
    Dermatol Nurs; 2007 Feb; 19(1):21-6; quiz 27. PubMed ID: 17330551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Porphyria cutanea tarda and lupus erythematosus].
    Köstler E; Heinicke HJ; Schneider F; Riedel H; Hensel J
    Z Gesamte Inn Med; 1989 Sep; 44(17):527-9. PubMed ID: 2588723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic lupus erythematosus and acute intermittent porphyria: coincidence or association ?
    Rosemarin JI; Nigro EJ; Levere RD; Mascarenhas BR
    Arthritis Rheum; 1982 Sep; 25(9):1134-7. PubMed ID: 7126298
    [No Abstract]   [Full Text] [Related]  

  • 26. First international meeting on mycophenolate mofetil: an advance in the treatment of lupus 27 April 2004, St Thomas' Hospital, London, UK.
    Vasoo S
    Lupus; 2004; 13(7):543-5. PubMed ID: 15352427
    [No Abstract]   [Full Text] [Related]  

  • 27. Urticarial vasculitis in systemic lupus erythematosus: fair response to prednisolone/dapsone and persistent hypocomplementemia.
    Nishijima C; Hatta N; Inaoki M; Sakai H; Takehara K
    Eur J Dermatol; 1999; 9(1):54-6. PubMed ID: 9920991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic lupus erythematosus. Diagnosis and treatment.
    Pisetsky DS; Gilkeson G; St Clair EW
    Med Clin North Am; 1997 Jan; 81(1):113-28. PubMed ID: 9012757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacotherapy of SLE].
    Nakazawa T; Kumagai S; Kogata Y
    Nihon Rinsho; 2005 May; 63 Suppl 5():253-9. PubMed ID: 15954358
    [No Abstract]   [Full Text] [Related]  

  • 30. Movement disorders in systemic lupus erythematosus and antiphospholipid syndrome--a video presentation.
    Ramcharan K; Abdool K; Persad N; Dyaanand H
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25953077
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical aspects and diagnosis of systemic lupus erythematosus].
    Hiepe F; Burmester GR
    Dtsch Med Wochenschr; 1996 Sep; 121(36):1095-100. PubMed ID: 8846755
    [No Abstract]   [Full Text] [Related]  

  • 32. Minimal-change nephropathy in systemic lupus erythematosus.
    Redondo-Pachón MD; Enríquez R; Sirvent AE; Andrada E; Millán I; Amorós F
    Nefrologia; 2012 May; 32(3):412-3. PubMed ID: 22592436
    [No Abstract]   [Full Text] [Related]  

  • 33. Porphyria cutanea tarda and systemic lupus erythematosus.
    Clemmensen O; Thomsen K
    Arch Dermatol; 1982 Mar; 118(3):160-2. PubMed ID: 7065663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic lupus erythematosus and the eye.
    Nguyen QD; Foster CS
    Int Ophthalmol Clin; 1998; 38(1):33-60. PubMed ID: 9532471
    [No Abstract]   [Full Text] [Related]  

  • 35. Current and emerging lupus treatments.
    Wallace D
    Am J Manag Care; 2001 Oct; 7(16 Suppl):S490-5. PubMed ID: 11680781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Systemic lupus erythematosus with neurologic onset and secondary antiphospholipid syndrome. A Case Study].
    Dima-Cozma C; Pandele GI; Rezuş E; Constantinescu A; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):254-8. PubMed ID: 16607781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on the treatment of systemic lupus erythematosus: therapeutic highlights from the Sixth International Lupus Conference.
    Abu-Shakra M; Buskila D
    Isr Med Assoc J; 2002 Jan; 4(1):71-3. PubMed ID: 11802320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New treatments for systemic diseases].
    Bader-Meunier B; Willems M
    Arch Pediatr; 2006 Jun; 13(6):596-8. PubMed ID: 16690273
    [No Abstract]   [Full Text] [Related]  

  • 39. [Coexistence of porphyria cutanea tarda and lupus erythematosus].
    Morvay M; Hunyadi J; Kószó F; Kiss M; Dobozy A; Simon N
    Dermatol Monatsschr; 1989; 175(1):20-7. PubMed ID: 2920861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute intermittent porphyria and systemic lupus erythematosus: report of a case and review of the literature.
    Filiotou A; Vaiopoulos G; Capsimali V; Stavrianeas N; Kaloterakis A
    Lupus; 2002; 11(3):190-2. PubMed ID: 11999885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.